Contact

Please use this form to send email to PR contact of this press release:
FDA GRANTS ORPHAN-DRUG DESIGNATION TO AN ORAL LIQUID SUSPENSION OF CELECOXIB TO TREAT ARTHRITIS IN CHILDREN

TO:
Inderjit Dev
NuBioPharma, LLC
919-236-3718

FROM:
Your Name:
Your Email:	Please check your email address!
Subject:
Message:
Confirmation code:	Please, do not fill this field.
Confirmation version code:	Please, do not change this field.
Javascript data:	Please, do not fill if your javascript is turned off.
Please type in the code you see in the image. Or click Send Email to generate another image instead.
	SEND EMAIL